Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock Patients

NCT05921825 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05921825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05921825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock Patients
Lead sponsor
Tanta University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
January 30, 2024
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

morality, sepsis, septic shock